These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 20017516)
1. Development of near-infrared fluorophore (NIRF)-labeled activity-based probes for in vivo imaging of legumain. Lee J; Bogyo M ACS Chem Biol; 2010 Feb; 5(2):233-43. PubMed ID: 20017516 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain. Lee J; Bogyo M Bioorg Med Chem Lett; 2012 Feb; 22(3):1340-3. PubMed ID: 22243962 [TBL] [Abstract][Full Text] [Related]
3. Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain. Sexton KB; Witte MD; Blum G; Bogyo M Bioorg Med Chem Lett; 2007 Feb; 17(3):649-53. PubMed ID: 17189693 [TBL] [Abstract][Full Text] [Related]
4. Legumain-Specific Near-Infrared Fluorescence "Turn On" for Tumor-Targeted Imaging. Zhao Y; Hai Z; Wang H; Su L; Liang G Anal Chem; 2018 Aug; 90(15):8732-8735. PubMed ID: 30027744 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of radioactive/fluorescent peptide probes for imaging of legumain activity. Fuchigami T; Itagaki K; Ishikawa N; Yoshida S; Nakayama M Bioorg Med Chem Lett; 2019 Oct; 29(19):126629. PubMed ID: 31445852 [TBL] [Abstract][Full Text] [Related]
6. Aza-peptide epoxides: a new class of inhibitors selective for clan CD cysteine proteases. Asgian JL; James KE; Li ZZ; Carter W; Barrett AJ; Mikolajczyk J; Salvesen GS; Powers JC J Med Chem; 2002 Nov; 45(23):4958-60. PubMed ID: 12408706 [TBL] [Abstract][Full Text] [Related]
7. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases). James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in the development of legumain-selective chemical probes and peptide prodrugs. Poreba M Biol Chem; 2019 Nov; 400(12):1529-1550. PubMed ID: 31021817 [TBL] [Abstract][Full Text] [Related]
9. A protease-responsive fluorescent probe for sensitive imaging of legumain activity in living tumor cells. Li X; Liu Q; Ye S; Wang S; Li K; Lv G; Peng Y; Qiu L; Lin J Chem Biol Drug Des; 2019 Aug; 94(2):1494-1503. PubMed ID: 31002467 [TBL] [Abstract][Full Text] [Related]
10. Functional imaging of legumain in cancer using a new quenched activity-based probe. Edgington LE; Verdoes M; Ortega A; Withana NP; Lee J; Syed S; Bachmann MH; Blum G; Bogyo M J Am Chem Soc; 2013 Jan; 135(1):174-82. PubMed ID: 23215039 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Blum G; von Degenfeld G; Merchant MJ; Blau HM; Bogyo M Nat Chem Biol; 2007 Oct; 3(10):668-77. PubMed ID: 17828252 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of alpha,beta-unsaturated ketone-based probes for papain-family cysteine proteases. Yang Z; Fonović M; Verhelst SH; Blum G; Bogyo M Bioorg Med Chem; 2009 Feb; 17(3):1071-8. PubMed ID: 18343672 [TBL] [Abstract][Full Text] [Related]
14. Peptide-based MRI contrast agent and near-infrared fluorescent probe for intratumoral legumain detection. Chen YJ; Wu SC; Chen CY; Tzou SC; Cheng TL; Huang YF; Yuan SS; Wang YM Biomaterials; 2014 Jan; 35(1):304-15. PubMed ID: 24120038 [TBL] [Abstract][Full Text] [Related]
15. Esomeprazole inhibits the lysosomal cysteine protease legumain to prevent cancer metastasis. Zhao T; Liu Y; Hao Y; Zhang W; Tao L; Wang D; Li Y; Liu Z; McKenzie EA; Zhao Q; Diao A Invest New Drugs; 2021 Apr; 39(2):337-347. PubMed ID: 32978718 [TBL] [Abstract][Full Text] [Related]